RCKT is currently covered by 7 analysts with average potential upside of $25.34 (130.23%) backed by 24 price targets and 44 ratings. Documented since 27-Nov-2018. Analyst's average stock valuation to be materialised ratio is 27.72% with an average time for price targets to be met of 105.89 days.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 01-Mar-2023.
Highest price target for RCKT is 45, Lowest price target is 9, average price target is 27.
Currently, out of the existing stock ratings of RCKT - 24 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
63
$46.33 (277.92%)
65
26 days ago
4/11 (36.36%)
$30.7 (211.35%)
107
Buy
60
$43.33 (259.93%)
60
27 days ago
0/5 (0%)
$41.66 (300.09%)
Buy
35
$18.33 (109.96%)
34
3 months 4 days ago
1/2 (50%)
$14.51 (74.26%)
145
Buy
33
$16.33 (97.96%)
34
4 months 20 days ago
1/4 (25%)
$12.09 (75.62%)
159
Buy
75
$56.4 (303.23%)
65
5 months 25 days ago
0/5 (0%)
$53.32 (190.35%)
What is RCKT(Rocket Pharmaceuticals, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RCKT(Rocket Pharmaceuticals, Inc) with a proven track record?
